» Articles » PMID: 30267533

Lack of Relationships Between Serum Prolactin Concentrations and Classical Cardiovascular Risk Factors in Eastern Croatian Older Adults

Overview
Journal Med Sci Monit
Date 2018 Sep 30
PMID 30267533
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Relationships between serum prolactin concentrations and various CV risk factors in older adults have rarely been assessed. The aim of this study was to examine the relationships between serum prolactin concentrations and CV risk factors in older patients with multiple CV risk factors. MATERIAL AND METHODS This case-control study included 92 patients, 50-89 years old (median, 69 years), with multiple CV risk factors. We used data from general practice electronic health records and biochemical laboratory tests. Patients were divided according to categories of CV risk factors. RESULTS Serum prolactin concentrations were significantly higher in elderly people (£65 vs. >65) and in men (70.65±58.02 vs. 150.82±114.05 mIU/L), as well as in patients with lower renal function (156.70±127.23 vs. 72.53±37.25 mIU/L, the bottom vs. top quartile of creatinine clearance), higher serum homocysteine and TSH concentrations, and in those who used NSAID and statins. Parameters indicating chronic inflammation (CRP) and renal function decline (creatinine clearance) were significantly and independently correlated with increased serum prolactin concentrations in multiple regression analysis. CONCLUSIONS When assessing the relationships between prolactin and CV risk factors in older people with multiple CV risk factors, the effect of renal function decline and chronic inflammation should receive attention.

Citing Articles

The role of prolactin/vasoinhibins in cardiovascular diseases.

Zhao H, Gong S, Shi Y, Luo C, Qiu H, He J Animal Model Exp Med. 2022; 6(2):81-91.

PMID: 35923071 PMC: 10158951. DOI: 10.1002/ame2.12264.


Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate.

Elgellaie A, Larkin T, Kaelle J, Mills J, Thomas S Compr Psychoneuroendocrinol. 2022; 6:100049.

PMID: 35757357 PMC: 9216608. DOI: 10.1016/j.cpnec.2021.100049.


J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.

Zhu C, Ma H, Huang D, Li G, Gao J, Cai M Front Endocrinol (Lausanne). 2022; 13:815995.

PMID: 35222274 PMC: 8875202. DOI: 10.3389/fendo.2022.815995.

References
1.
Freeman M, Kanyicska B, Lerant A, Nagy G . Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000; 80(4):1523-631. DOI: 10.1152/physrev.2000.80.4.1523. View

2.
Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin A, Monti D . The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol. 2000; 35(6-7):879-96. DOI: 10.1016/s0531-5565(00)00172-8. View

3.
Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters E . Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. J Neuroimmunol. 2001; 120(1-2):58-66. DOI: 10.1016/s0165-5728(01)00420-9. View

4.
Hansson G . Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol. 2001; 21(12):1876-90. DOI: 10.1161/hq1201.100220. View

5.
Limas C, Kroupis C, Haidaroglou A, Cokkinos D . Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. Eur J Clin Invest. 2002; 32(2):74-8. DOI: 10.1046/j.1365-2362.2002.00924.x. View